387 related articles for article (PubMed ID: 16495519)
1. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.
Sharma J; Zhong Y; Dong F; Piper JM; Wang G; Zhong G
Infect Immun; 2006 Mar; 74(3):1490-9. PubMed ID: 16495519
[TBL] [Abstract][Full Text] [Related]
2. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.
Chen C; Chen D; Sharma J; Cheng W; Zhong Y; Liu K; Jensen J; Shain R; Arulanandam B; Zhong G
Infect Immun; 2006 Aug; 74(8):4826-40. PubMed ID: 16861671
[TBL] [Abstract][Full Text] [Related]
3. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
[TBL] [Abstract][Full Text] [Related]
4. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner.
Li Z; Zhong Y; Lei L; Wu Y; Wang S; Zhong G
BMC Microbiol; 2008 Jun; 8():90. PubMed ID: 18541036
[TBL] [Abstract][Full Text] [Related]
5. Localization and characterization of the hypothetical protein CT440 in Chlamydia trachomatis-infected cells.
Li Z; Huang Q; Su S; Zhou Z; Chen C; Zhong G; Wu Y
Sci China Life Sci; 2011 Nov; 54(11):1048-54. PubMed ID: 22173312
[TBL] [Abstract][Full Text] [Related]
6. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
[TBL] [Abstract][Full Text] [Related]
7. [Localization of the hypothetical protein CT249 in the Chlamydia trachomatis inclusion membrane].
Jia TJ; Liu DW; Luo JH; Zhong GM
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):645-8. PubMed ID: 17944365
[TBL] [Abstract][Full Text] [Related]
8. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
[TBL] [Abstract][Full Text] [Related]
9. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.
Morrison RP
Semin Immunol; 1991 Jan; 3(1):25-33. PubMed ID: 1680011
[TBL] [Abstract][Full Text] [Related]
10. Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection.
Olsen AW; Follmann F; Jensen K; Højrup P; Leah R; Sørensen H; Hoffmann S; Andersen P; Theisen M
J Infect Dis; 2006 Nov; 194(9):1258-66. PubMed ID: 17041852
[TBL] [Abstract][Full Text] [Related]
11. Antigenic profiling of a Chlamydia trachomatis gene-expression library.
Follmann F; Olsen AW; Jensen KT; Hansen PR; Andersen P; Theisen M
J Infect Dis; 2008 Mar; 197(6):897-905. PubMed ID: 18288899
[TBL] [Abstract][Full Text] [Related]
12. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
Barker CJ; Beagley KW; Hafner LM; Timms P
Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection.
Patel HC; Goh BT; Viswalingam ND; Treharne JD
Genitourin Med; 1995 Apr; 71(2):94-7. PubMed ID: 7744422
[TBL] [Abstract][Full Text] [Related]
14. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane.
Bannantine JP; Griffiths RS; Viratyosin W; Brown WJ; Rockey DD
Cell Microbiol; 2000 Feb; 2(1):35-47. PubMed ID: 11207561
[TBL] [Abstract][Full Text] [Related]
15. Human antibody and antigen response to IncA antibody of Chlamydia trachomatis.
Tsai PY; Hsu MC; Huang CT; Li SY
Int J Immunopathol Pharmacol; 2007; 20(1):156-61. PubMed ID: 17346439
[TBL] [Abstract][Full Text] [Related]
16. Host immune response in chlamydial cervicitis.
Mittal A; Kapur S; Gupta S
Br J Biomed Sci; 1996 Sep; 53(3):214-20. PubMed ID: 8914349
[TBL] [Abstract][Full Text] [Related]
17. Primary and secondary immune responses of mucosal and peripheral lymphocytes during Chlamydia trachomatis infection.
Vats V; Agrawal T; Salhan S; Mittal A
FEMS Immunol Med Microbiol; 2007 Mar; 49(2):280-7. PubMed ID: 17328762
[TBL] [Abstract][Full Text] [Related]
18. Serological response to pgp3 protein in animal and human chlamydial infections.
Donati M; Laroucau K; Storni E; Mazzeo C; Magnino S; Di Francesco A; Baldelli R; Ceglie L; Renzi M; Cevenini R
Vet Microbiol; 2009 Mar; 135(1-2):181-5. PubMed ID: 18945555
[TBL] [Abstract][Full Text] [Related]
19. Antibody-neutralizing activity against all urogenital Chlamydia trachomatis serovars in Chlamydia suis-infected pigs.
Donati M; Di Francesco A; Delucca F; Di Paolo M; Battilani M; Balboni A; Baldelli R; Cevenini R
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):125-8. PubMed ID: 21214636
[TBL] [Abstract][Full Text] [Related]
20. Specific antigens of Chlamydia pecorum and their homologues in C psittaci and C trachomatis.
Baghian A; Kousoulas K; Truax R; Storz J
Am J Vet Res; 1996 Dec; 57(12):1720-5. PubMed ID: 8950425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
